草酸铂或顺铂联合氟脲嘧啶及醛氢叶酸治疗晚期胃癌的对比研究

Comparative Study on Patients with Advanced Gastric Cancer Treated with Oxaliplatin or Cisplatin Combining with 5-Fluorouracil and Leucovorin

  • 摘要: 目的 :比较L-OHP+CF+5-FU方案与DDP+CF+5-FU方案对初次化疗的Ⅲ期胃癌患者的疗效、不良反应及生活质量的改善情况。 方法 :A组(34例)接受L-OHP+CF+5-FU方案治疗;B组(36例)接受DDP+CF+5-FU方案治疗。两组均以3周为1周期,重复3个周期。客观疗效与不良反应按WHO标准进行评价,生活质量根据临床受益疗效评价。 结果 :A、B两组客观疗效(CR+PR)分别为52.9%及50.0%,P<0.05;白细胞减少及恶心呕吐反应B组均较A组明显(P<0.01);外周神经炎A组比B组明显(P<0.05),但较轻微,均在Ⅰ~Ⅱ度范围内。两组均未发现其他严重的不良反应。临床受益疗效A组高于B组(P<0.05)。 结论 :L-OHP+CF+5-FU方案与DDP+CF+5-FU方案治疗晚期胃癌的客观疗效无明显差异性,但前者耐受性好,患者生活质量改善明显。

     

    Abstract: Objective :To compare the effect,toxicity and quality of life(QQL)between Oxaliplatin plus leucovorin and 5-Fluorouracil(L-OHP+CF+5Fu)regimen and Cisplatin plus Leucovorin and 5-Fluorouracil(DDP+CF+5Fu)regimen in primary patients with advanced Gastric Cancer(stage IV). Methods :Group A(34 cases)were treated with L-OHP+CF+5Fu regimen and group B(36 cases)were treated with DDP+CF+5-Fu regimen.Both regimens were repeated every 3 weeks for three cycles.tumor response and cytotoxic reactions were assessed by WHO criteria.QOL was evaluated by clinical benefit response. Results :The response rate(CR+PR)was 52.9% in group A compared to 50.0% in group B(P<0.05).Leukopenia,nausea and vomiting in group B were more serious than those in group A(P<0.01).Peripheral neuritis had higher incidence in group A(P<0.05),but that was slight(within I and II degree).No other serious adverse reactions occurred in either group.Clinial benefit response in group A was higher than that in group B(P<0.05). Conclusion The present study indicated that L-OHP+CF+5-Fu regimen had lower toxicity,longer median survival time and better QOL than DDP+CF+5-Fu regimen for advanced Gastric cancer,however there was no significant statistical difference in the Objective response rate between the two groups.

     

/

返回文章
返回